Steffen Heeger

Chief Tech/Sci/R&D Officer at ACTINIUM PHARMACEUTICALS, INC.

Net worth: 156 945 $ as of 31/08/2026

Health Technology

Consumer Services

Profile

Steffen Heeger is Chief Medical Officer at Actinium Pharmaceuticals, Inc. since 2026.
Former positions include Head-Clinical Development at MorphoSys AG, Head-Medical Affairs at Merck Serono SA, Chief Medical Officer at Ryvu Therapeutics SA, and Chief Medical Officer at Shanghai Full-Life Technologies Co., Ltd. Education includes a doctorate from Ruprecht-Karls-Universität Heidelberg.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ACTINIUM PHARMACEUTICALS, INC. 0.49%	03/09/2026	153,868 ( 0.49% )	156 945 $	31/08/2026

Steffen Heeger active positions

Companies	Position	Start
ACTINIUM PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	01/06/2026

All active positions of Steffen Heeger

Former positions of Steffen Heeger

Companies	Position	End
Shanghai Full-Life Technologies Co. Ltd. Shanghai Full-Life Technologies Co. Ltd. BiotechnologyHealth Technology Engages in radiopharmaceutical research & development, production & commercialization in order to deliver clinical impact for patients	Chief Tech/Sci/R&D Officer	-
RYVU THERAPEUTICS S.A.	Chief Tech/Sci/R&D Officer	-
Merck Serono SA Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism	Corporate Officer/Principal	-
MORPHOSYS AG	Corporate Officer/Principal	-

See the detail of Steffen Heeger's experience

Training of Steffen Heeger

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Steffen Heeger's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
MorphoSys AG MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services	Health Technology
Ruprecht-Karls-Universität Heidelberg Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Merck Serono SA Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism	Health Technology
Ryvu Therapeutics SA Ryvu Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops and sells therapies for precision oncology	Health Technology
Actinium Pharmaceuticals, Inc. Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers	Health Technology
Shanghai Full-Life Technologies Co. Ltd. Shanghai Full-Life Technologies Co. Ltd. BiotechnologyHealth Technology Engages in radiopharmaceutical research & development, production & commercialization in order to deliver clinical impact for patients	Health Technology